Myron Kaplan, Director at CorMedix Inc. (CRMD), bought 6,000 shares at $4.54 ($27K) on 2023-05-18, disclosed to the SEC on 2023-05-19.
Seasonal purchase ($27k) by Director — this insider has traded CRMD in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CRMD | BUY | 2021-11-19 | $51K | — | Filing → |
| CRMD | BUY | 2021-05-19 | $90K | — | Filing → |
| CRMD | BUY | 2020-09-04 | $131K | — | Filing → |